Teri Carlson, RN
Final Project
2010 MMI 406
This project is
focused on the
creation of a
Gestational
Diabetes Clinical
Decision Support
System.
What is Gestational Diabetes ?
 The American Diabetes Association defines
Gestational diabetes mellitus (GDM) as any degree of
glucose intolerance with onset or first recognition
during pregnancy.
 It generally occurs between the
24-28 week of pregnancy.
 It is reported that up to 7% of all
pregnancies are complicated by
GDM.
Mother
Fetus
Maternal/Fetal
Dyad
Gestational
Diabetes
Preeclampsia
C-section
Type 2 DM
biomedme.com/.../01/gestational-diabetes.jpg
Perinatal mortality
Macrosomia
Birth trauma
Hyperbilirubinemia
Neonatal
Hypoglycemia
Cost of GDM to the Nation
In 2007 it cost of GDM was $636 million for the 180,000
pregnancies where gestational diabetes was diagnosed.
Maternal $596 million
Neonatal $40 million
Total $636 million
The Cost of Gestational Diabetes to the United States in 2007
Medicaid
• $230
million
• 36%
Insurance
• $355
million
• 56%
Self-pay
• $51
million
• 8%
The Keys to Successful Management of GDM
preventing extra healthcare costs
and
negative outcomes for the mother / infant
“Early Identification”
 All women will be screened for risk and possible
pre-existing diabetes that they were unaware of
 Patient education
 Monitoring and if
necessary pharmacological
treatment
 The Ob-gyn Practice will use a
diabetic dashboard as a tool.
 The clinicians can use to screen,
identify and monitor all the
pregnant women who come to
their practice
 Using nationally established
GDM best practice
recommendations
Care provided by Ob-gyn Practice
Best
Clinical
Practice
Disease
Management
Patient
Education
Remote
Monitoring
Prepared
Proactive
Providers
Informed
Motivated
Patients
Quality Care…..Lower Costs…..Better Outcomes
Components
Outcomes
Management
Participants
GDM Registryhttp://ww.delphihealth.com/sol_overview.html
The Registry decision support information is based on the American Diabetes
Association best clinical practices for Gestational Diabetes
GDM Dashboard
Decision Tree
All moms undergo a GDM
screening at the first visit in the
first trimester
Not at
Risk
At Risk
Second screening
occurs in the 2nd at
trimester 24-26wks
Not Treat for
GDM
Treat for
GDM
Wireless Home Monitoring - BG reading is done at home - The results are sent wireless to the Ob-gyn
practice Dashboard - Built in alerts will show when the mother is not in the desired BG range - The real
time data - leads to real time interventions - versus waiting for the next office visit.
The cost benefit of this is a value add, because early treatment equals less long run complications to
both mother and infant.
Third
Screening at
32-34 weeks
Not Treat
for GDM
Treat for
GDM
Decision Tree for Pharmacological
Treatment of GDM
http://spectrum.diabetesjournals.org/content/20/2/101/F1.expansion.html
Obgyn GDM Dashboard
Patients with Remote Blood
Glucose Monitoring
Patients Referred to
Perinatologyg
Wireless Diabetic Monitoring
http://www.medgadget.com/archives/2009/07/myglucohealth_adds_sms_email_messaging_capabilities.html
Significance of the Technology in Disease Management
Technology Provides
 A new way of healthcare delivery, one that
decreases healthcare costs
 An avenue to find the best practice interventions
and solutions
 A real time monitoring and treatment of
GDM resulting in a decrease of the
associated diabetic co-morbidities
DSS GDM final presentation pp (4)

DSS GDM final presentation pp (4)

  • 1.
    Teri Carlson, RN FinalProject 2010 MMI 406
  • 2.
    This project is focusedon the creation of a Gestational Diabetes Clinical Decision Support System.
  • 3.
    What is GestationalDiabetes ?  The American Diabetes Association defines Gestational diabetes mellitus (GDM) as any degree of glucose intolerance with onset or first recognition during pregnancy.  It generally occurs between the 24-28 week of pregnancy.  It is reported that up to 7% of all pregnancies are complicated by GDM.
  • 4.
  • 5.
    Cost of GDMto the Nation In 2007 it cost of GDM was $636 million for the 180,000 pregnancies where gestational diabetes was diagnosed. Maternal $596 million Neonatal $40 million Total $636 million The Cost of Gestational Diabetes to the United States in 2007 Medicaid • $230 million • 36% Insurance • $355 million • 56% Self-pay • $51 million • 8%
  • 6.
    The Keys toSuccessful Management of GDM preventing extra healthcare costs and negative outcomes for the mother / infant “Early Identification”  All women will be screened for risk and possible pre-existing diabetes that they were unaware of  Patient education  Monitoring and if necessary pharmacological treatment  The Ob-gyn Practice will use a diabetic dashboard as a tool.  The clinicians can use to screen, identify and monitor all the pregnant women who come to their practice  Using nationally established GDM best practice recommendations
  • 7.
    Care provided byOb-gyn Practice Best Clinical Practice Disease Management Patient Education Remote Monitoring Prepared Proactive Providers Informed Motivated Patients Quality Care…..Lower Costs…..Better Outcomes Components Outcomes Management Participants GDM Registryhttp://ww.delphihealth.com/sol_overview.html The Registry decision support information is based on the American Diabetes Association best clinical practices for Gestational Diabetes
  • 8.
    GDM Dashboard Decision Tree Allmoms undergo a GDM screening at the first visit in the first trimester Not at Risk At Risk Second screening occurs in the 2nd at trimester 24-26wks Not Treat for GDM Treat for GDM Wireless Home Monitoring - BG reading is done at home - The results are sent wireless to the Ob-gyn practice Dashboard - Built in alerts will show when the mother is not in the desired BG range - The real time data - leads to real time interventions - versus waiting for the next office visit. The cost benefit of this is a value add, because early treatment equals less long run complications to both mother and infant. Third Screening at 32-34 weeks Not Treat for GDM Treat for GDM
  • 9.
    Decision Tree forPharmacological Treatment of GDM http://spectrum.diabetesjournals.org/content/20/2/101/F1.expansion.html
  • 10.
    Obgyn GDM Dashboard Patientswith Remote Blood Glucose Monitoring Patients Referred to Perinatologyg
  • 11.
  • 12.
    Significance of theTechnology in Disease Management Technology Provides  A new way of healthcare delivery, one that decreases healthcare costs  An avenue to find the best practice interventions and solutions  A real time monitoring and treatment of GDM resulting in a decrease of the associated diabetic co-morbidities